FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003119155> ?p ?o ?g. }

• W2003119155 endingPage "16" @default.
• W2003119155 startingPage "10" @default.
• W2003119155 abstract "Cyclooxygenase (COX) enzyme-dependent arachidonic acid metabolites occupy key positions in important physiologic processes such as immunity, reproduction, and vascular integrity. Large retrospective and prospective population-based studies have shown that the use of both nonselective, nonsteroidal anti-inflammatory drugs and selective COX-2 inhibitors are associated with decreased colorectal cancer incidence and mortality rate. A majority of animal studies provide strong evidence that prevention of intestinal tumors is more efficiently accomplished by COX-2 selective inhibition rather than by COX-1 suppression. The inducible COX-2 isoform is overexpressed in colorectal tissues and is associated with critical events of tumorigenesis. COX-2 expression correlates with expression of angiogenic factors and new blood vessel formation. Inhibition of COX-2 favors apoptosis and causes a dose-dependent decline of tumor growth and metastasis in these models. These data, together with the fact that COX-2 inhibitors cause less toxic side effects compared with nonselective nonsteroidal anti-inflammatory drugs, render these new compounds promising candidates in chemoprevention and treatment of colorectal cancer. Results from initial clinical trials suggest that COX-2 inhibitors may be able to reduce the polyp burden in patients with familial polyposis coli. However, further clinical studies are needed to evaluate whether COX-2 inhibition will be effective in all types of colorectal tumor tissues. This is especially true for neoplastic lesions that express COX-2 at a lower level (eg, hereditary nonpolyposis colorectal cancer) and for colorectal tumors of patients with inflammatory bowel disease. In summary, COX-2 inhibitors represent a new and very promising group of chemotherapeutic agents with great potential for both colorectal cancer prevention and treatment. Semin Oncol 30 (suppl 6):10-16. © 2003 Elsevier Inc. All rights reserved." @default.
• W2003119155 created "2016-06-24" @default.
• W2003119155 creator A5040708686 @default.
• W2003119155 creator A5045441776 @default.
• W2003119155 date "2003-06-01" @default.
• W2003119155 modified "2023-10-18" @default.
• W2003119155 title "Cyclooxygenase-2 inhibitors in colorectal cancer" @default.
• W2003119155 cites W1514189093 @default.
• W2003119155 cites W1529151652 @default.
• W2003119155 cites W1648593433 @default.
• W2003119155 cites W1650984530 @default.
• W2003119155 cites W1783022590 @default.
• W2003119155 cites W1868796410 @default.
• W2003119155 cites W1995978700 @default.
• W2003119155 cites W1996715439 @default.
• W2003119155 cites W2004724470 @default.
• W2003119155 cites W2008395005 @default.
• W2003119155 cites W2008715595 @default.
• W2003119155 cites W2010404222 @default.
• W2003119155 cites W2011613713 @default.
• W2003119155 cites W2018348035 @default.
• W2003119155 cites W2023040133 @default.
• W2003119155 cites W2024065712 @default.
• W2003119155 cites W2034468337 @default.
• W2003119155 cites W2034623791 @default.
• W2003119155 cites W2037656993 @default.
• W2003119155 cites W2043707891 @default.
• W2003119155 cites W2043944220 @default.
• W2003119155 cites W2049821512 @default.
• W2003119155 cites W2051686420 @default.
• W2003119155 cites W2055951936 @default.
• W2003119155 cites W2059813946 @default.
• W2003119155 cites W2070609164 @default.
• W2003119155 cites W2077991158 @default.
• W2003119155 cites W2083225065 @default.
• W2003119155 cites W2084647545 @default.
• W2003119155 cites W2096652490 @default.
• W2003119155 cites W2097716284 @default.
• W2003119155 cites W2097997344 @default.
• W2003119155 cites W2123927174 @default.
• W2003119155 cites W2124678826 @default.
• W2003119155 cites W2129960830 @default.
• W2003119155 cites W2134818882 @default.
• W2003119155 cites W2135938816 @default.
• W2003119155 cites W2142849884 @default.
• W2003119155 cites W2145149010 @default.
• W2003119155 cites W2145925849 @default.
• W2003119155 cites W2147433377 @default.
• W2003119155 cites W2148122132 @default.
• W2003119155 cites W2148907720 @default.
• W2003119155 cites W2149233326 @default.
• W2003119155 cites W2150586689 @default.
• W2003119155 cites W2151324279 @default.
• W2003119155 cites W2159767540 @default.
• W2003119155 cites W2165663767 @default.
• W2003119155 cites W2167250718 @default.
• W2003119155 cites W2170717609 @default.
• W2003119155 cites W2170720047 @default.
• W2003119155 cites W2318925269 @default.
• W2003119155 cites W2330709704 @default.
• W2003119155 cites W2336169581 @default.
• W2003119155 cites W2336215030 @default.
• W2003119155 doi "https://doi.org/10.1016/s0093-7754(03)70020-7" @default.
• W2003119155 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12802790" @default.
• W2003119155 hasPublicationYear "2003" @default.
• W2003119155 type Work @default.
• W2003119155 sameAs 2003119155 @default.
• W2003119155 citedByCount "25" @default.
• W2003119155 countsByYear W20031191552015 @default.
• W2003119155 countsByYear W20031191552016 @default.
• W2003119155 countsByYear W20031191552017 @default.
• W2003119155 countsByYear W20031191552018 @default.
• W2003119155 countsByYear W20031191552022 @default.
• W2003119155 crossrefType "journal-article" @default.
• W2003119155 hasAuthorship W2003119155A5040708686 @default.
• W2003119155 hasAuthorship W2003119155A5045441776 @default.
• W2003119155 hasConcept C111669997 @default.
• W2003119155 hasConcept C121608353 @default.
• W2003119155 hasConcept C126322002 @default.
• W2003119155 hasConcept C143998085 @default.
• W2003119155 hasConcept C181199279 @default.
• W2003119155 hasConcept C2779013556 @default.
• W2003119155 hasConcept C2779689624 @default.
• W2003119155 hasConcept C2908647359 @default.
• W2003119155 hasConcept C502942594 @default.
• W2003119155 hasConcept C50382708 @default.
• W2003119155 hasConcept C526805850 @default.
• W2003119155 hasConcept C55493867 @default.
• W2003119155 hasConcept C555283112 @default.
• W2003119155 hasConcept C71924100 @default.
• W2003119155 hasConcept C86803240 @default.
• W2003119155 hasConcept C99454951 @default.
• W2003119155 hasConceptScore W2003119155C111669997 @default.
• W2003119155 hasConceptScore W2003119155C121608353 @default.
• W2003119155 hasConceptScore W2003119155C126322002 @default.
• W2003119155 hasConceptScore W2003119155C143998085 @default.
• W2003119155 hasConceptScore W2003119155C181199279 @default.
• W2003119155 hasConceptScore W2003119155C2779013556 @default.

• next